T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$3.17B |
| 2 |
Nike
NKE
|
+$1.94B |
| 3 |
Bank of America
BAC
|
+$1.84B |
| 4 |
FedEx
FDX
|
+$1.78B |
| 5 |
PNC Financial Services
PNC
|
+$1.61B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$4.1B |
| 2 |
Fortive
FTV
|
+$2.54B |
| 3 |
Linde
LIN
|
+$1.53B |
| 4 |
Alibaba
BABA
|
+$1.35B |
| 5 |
Willis Towers Watson
WTW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.61% |
| 2 | Healthcare | 16.74% |
| 3 | Consumer Discretionary | 15.8% |
| 4 | Financials | 11.46% |
| 5 | Communication Services | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Tenet Healthcare
THC
$21.5B
| $1.65M | ﹤0.01% |
67,208
+594
| +0.9% | +$15.2K |
|
1602
Mercury Systems
MRCY
$6.7B
| $1.64M | ﹤0.01% |
21,228
-6,487
| -23% | -$492K |
|
1603
Donaldson
DCI
$11.2B
| $1.64M | ﹤0.01% |
35,270
+1,359
| +4% | +$66.1K |
|
|
BBBY
1604
DELISTED
Bed Bath & Beyond Inc
BBBY
| $1.64M | ﹤0.01% |
109,257
-21,488
| -16% | -$248K |
|
1605
Werner Enterprises
WERN
$2.31B
| $1.63M | ﹤0.01% |
38,859
+8,733
| +29% | +$387K |
|
1606
Wingstop
WING
$3.05B
| $1.63M | ﹤0.01% |
11,913
-334
| -3% | -$49.1K |
|
1607
Harmony Gold Mining
HMY
$12B
| $1.63M | ﹤0.01% |
308,571
+37,271
| +14% | +$222K |
|
1608
LivePerson
LPSN
$35.9M
| $1.62M | ﹤0.01% |
2,078
+670
| +48% | +$503K |
|
|
XEC
1609
DELISTED
CIMAREX ENERGY CO
XEC
| $1.62M | ﹤0.01% |
66,596
+2,687
| +4% | +$70.8K |
|
1610
Graham Holdings Company
GHC
$5.03B
| $1.6M | ﹤0.01% |
3,971
-263
| -6% | -$105K |
|
1611
iShare MSCI Eurozone ETF
EZU
$9.96B
| $1.6M | ﹤0.01% |
42,300
+24,300
| +135% | +$941K |
|
|
QTS
1612
DELISTED
QTS REALTY TRUST, INC.
QTS
| $1.6M | ﹤0.01% |
25,449
+4,916
| +24% | +$328K |
|
|
X
1613
DELISTED
US Steel
X
| $1.6M | ﹤0.01% |
218,343
+46,476
| +27% | +$352K |
|
1614
Coherus Oncology
CHRS
$181M
| $1.6M | ﹤0.01% |
87,155
+35,875
| +70% | +$667K |
|
1615
Pediatrix Medical
MD
$2.15B
| $1.6M | ﹤0.01% |
98,028
+5,228
| +6% | +$97.3K |
|
1616
Silicon Laboratories
SLAB
$7.3B
| $1.6M | ﹤0.01% |
16,306
-1,944
| -11% | -$195K |
|
1617
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $1.59M | ﹤0.01% |
4,761
-79,427
| -94% | -$26.3M |
|
1618
Insight Enterprises
NSIT
$4.54B
| $1.59M | ﹤0.01% |
28,162
-2,797
| -9% | -$150K |
|
1619
Intercorp Financial Services
IFS
$6.06B
| $1.58M | ﹤0.01% |
68,400
-1,246
| -2% | -$31.3K |
|
1620
MGIC Investment
MTG
$6.29B
| $1.58M | ﹤0.01% |
178,458
-1,052
| -0.6% | -$8.96K |
|
1621
World Kinect Corp
WKC
$1.89B
| $1.57M | ﹤0.01% |
74,171
+7,600
| +11% | +$186K |
|
1622
Credit Acceptance
CACC
$5.99B
| $1.57M | ﹤0.01% |
4,633
-164
| -3% | -$69K |
|
1623
Teradata
TDC
$2.49B
| $1.57M | ﹤0.01% |
69,119
+677
| +1% | +$15K |
|
|
ROIC
1624
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $1.57M | ﹤0.01% |
150,432
+23,800
| +19% | +$260K |
|
|
STL
1625
DELISTED
Sterling Bancorp
STL
| $1.56M | ﹤0.01% |
148,694
-108
| -0.1% | -$1.22K |
|
Similar funds
T. Rowe Price Associates's Q3 2020 Portfolio in Review
As of Q3 2020, T. Rowe Price Associates held 2,679 positions worth $864B, up 8.7% from $795B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2020 filing shows 185 new, 873 increased, 1,330 reduced and 90 closed positions. Its largest new stake was nCino: 5,133,240 shares worth $395M. The largest sale was People Inc, an estimated $4.1B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2020 buy was nCino: 5,133,240 shares worth $395M.
- T. Rowe Price Associates added most to Match Group in Q3 2020, an estimated $3.17B increase.
- T. Rowe Price Associates's biggest Q3 2020 reduction was People Inc, cutting an estimated $4.1B.
- T. Rowe Price Associates fully exited 58.com Inc in Q3 2020, selling an estimated $468M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $864B portfolio in Q3 2020.
- T. Rowe Price Associates opened 185 new positions and closed 90 in Q3 2020.
- T. Rowe Price Associates's portfolio value rose 8.7% quarter-over-quarter to $864B.
Based on T. Rowe Price Associates's 13F filing for Q3 2020, filed 16 Nov 2020.